Investors | News Stock Info Share Structure News Releases Presentations Product Info Media Financials Annual General Meeting 2019 September 12, 2019LexaGene Announces Second Cannabis Testing Laboratory Beta Test Site September 5, 2019LexaGene Reports on Beta Results from Cannabis-Focused Testing Laboratory August 8, 2019LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory July 30, 2019LexaGene Approved by CDC and FDA Antibiotic Resistance Isolate Bank to Receive Samples July 17, 2019LexaGene Files Three Additional US Patents Covering Technology July 10, 2019Beta Testing Results at Mass Vet June 6, 2019LexaGene Hosts Investor Webinar June 5, 2019LexaGene Places its First Beta Prototype into Veterinary Hospital May 15, 2019LexaGene Completes Development of Antibiotic Resistance Panel April 30, 2019LexaGene’s Technology Detects a Common Fungus That Damages Agricultural Crops April 24, 2019LexaGene’s Technology Identifies Genetic Mutations Directly from Cheek Swabs April 16, 2019LexaGene Engages Bristol to Provide Investor Relations Services 123›»
